Occupe actuellement un poste chez Collegium Pharmaceutical Inc
Position | Company | Period |
---|---|---|
President, Chief Executive Officer, Director | Collegium Pharmaceutical Inc | 1 juillet 2018 - |
Chief Operating Officer, Executive Vice President | Collegium Pharmaceutical Inc | 31 mai 2017 - 1 juillet 2018 |
Rechercher
Date de notification | Date de transaction | A/V Type de transaction |
Nb. d'actions Prix Valeur |
Nombre d'actions | Prix | Valeur totale | Détails | |
---|---|---|---|---|---|---|---|---|
2023-12-22 | 2023-12-21 |
Collegium Pharmaceutical Inc
(COLL)
|
VP Vente planifiée |
4 357
-1.6%
30,38132 377 USD |
4 357 -1.6% | 30,38 | 132 377 USD | |
2023-12-20 | 2023-12-20 |
Collegium Pharmaceutical Inc
(COLL)
|
VP Vente planifiée |
26 454
-8.8%
30,40804 210 USD |
26 454 -8.8% | 30,40 | 804 210 USD | |
2023-12-20 | 2023-12-19 |
Collegium Pharmaceutical Inc
(COLL)
|
VP Vente planifiée |
14 516
-5.0%
30,03435 942 USD |
14 516 -5.0% | 30,03 | 435 942 USD | |
2023-12-20 | 2023-12-18 |
Collegium Pharmaceutical Inc
(COLL)
|
VP Vente planifiée |
27 798
-9.2%
30,04834 935 USD |
27 798 -9.2% | 30,04 | 834 935 USD | |
2023-06-02 | 2023-06-02 |
Collegium Pharmaceutical Inc
(COLL)
|
VP Vente planifiée |
1 000
-0.4%
22,2522 251 USD |
1 000 -0.4% | 22,25 | 22 251 USD | |
2023-06-02 | 2023-06-02 |
Collegium Pharmaceutical Inc
(COLL)
|
VP Vente planifiée |
30 272
-9.9%
21,58653 173 USD |
30 272 -9.9% | 21,58 | 653 173 USD | |
2023-06-02 | 2023-06-01 |
Collegium Pharmaceutical Inc
(COLL)
|
VP Vente planifiée |
31 272
-9.3%
22,09690 758 USD |
31 272 -9.3% | 22,09 | 690 758 USD | |
2023-06-01 | 2023-05-31 |
Collegium Pharmaceutical Inc
(COLL)
|
VP Vente planifiée |
31 272
-8.5%
21,87683 797 USD |
31 272 -8.5% | 21,87 | 683 797 USD | |
2023-06-01 | 2023-05-30 |
Collegium Pharmaceutical Inc
(COLL)
|
VP Vente planifiée |
31 271
-7.8%
21,90684 907 USD |
31 271 -7.8% | 21,90 | 684 907 USD | |
2022-12-27 | 2022-12-27 |
Collegium Pharmaceutical Inc
(COLL)
|
VP Vente planifiée |
400
-0.2%
24,199 676 USD |
400 -0.2% | 24,19 | 9 676 USD | |
2022-12-27 | 2022-12-27 |
Collegium Pharmaceutical Inc
(COLL)
|
VP Vente planifiée |
1 804
-0.7%
23,6542 665 USD |
1 804 -0.7% | 23,65 | 42 665 USD | |
2022-12-27 | 2022-12-23 |
Collegium Pharmaceutical Inc
(COLL)
|
VP Vente planifiée |
147
-0.1%
23,003 381 USD |
147 -0.1% | 23,00 | 3 381 USD | |
2022-12-27 | 2022-12-22 |
Collegium Pharmaceutical Inc
(COLL)
|
VP Vente planifiée |
110
-0.0%
23,002 530 USD |
110 -0.0% | 23,00 | 2 530 USD | |
2022-12-05 | 2022-12-02 |
Collegium Pharmaceutical Inc
(COLL)
|
VP Vente planifiée |
54 400
-16.8%
23,071 255 008 USD |
54 400 -16.8% | 23,07 | 1 255 008 USD | |
2022-12-05 | 2022-12-01 |
Collegium Pharmaceutical Inc
(COLL)
|
VP Vente planifiée |
76 653
-19.2%
22,471 722 393 USD |
76 653 -19.2% | 22,47 | 1 722 393 USD | |
2022-11-30 | 2022-11-28 |
Collegium Pharmaceutical Inc
(COLL)
|
VP Vente planifiée |
43
-0.0%
22,00946 USD |
43 -0.0% | 22,00 | 946 USD | |
2022-11-25 | 2022-11-22 |
Collegium Pharmaceutical Inc
(COLL)
|
VP Vente planifiée |
65
-0.0%
22,001 430 USD |
65 -0.0% | 22,00 | 1 430 USD | |
2022-11-22 | 2022-11-18 |
Collegium Pharmaceutical Inc
(COLL)
|
VP Vente planifiée |
1 989
-0.6%
22,0243 798 USD |
1 989 -0.6% | 22,02 | 43 798 USD | |
2021-06-03 | 2021-06-02 |
Collegium Pharmaceutical Inc
(COLL)
|
VP Vente planifiée |
5 861
-2.1%
22,81133 689 USD |
5 861 -2.1% | 22,81 | 133 689 USD | |
2021-06-03 | 2021-06-01 |
Collegium Pharmaceutical Inc
(COLL)
|
VP Vente planifiée |
10 829
-3.8%
23,33252 641 USD |
10 829 -3.8% | 23,33 | 252 641 USD | |
2021-06-03 | 2021-06-01 |
Collegium Pharmaceutical Inc
(COLL)
|
VP Vente planifiée |
5 376
-1.9%
22,93123 272 USD |
5 376 -1.9% | 22,93 | 123 272 USD | |
2021-03-03 | 2021-03-01 |
Collegium Pharmaceutical Inc
(COLL)
|
VP Vente planifiée |
9 809
-3.4%
23,30228 550 USD |
9 809 -3.4% | 23,30 | 228 550 USD | |
2021-03-03 | 2021-03-01 |
Collegium Pharmaceutical Inc
(COLL)
|
VP Vente planifiée |
54 959
-16.0%
22,561 239 875 USD |
54 959 -16.0% | 22,56 | 1 239 875 USD | |
2020-06-02 | 2020-06-02 |
Collegium Pharmaceutical Inc
(COLL)
|
VP Vente planifiée |
100
-0.1%
21,302 130 USD |
100 -0.1% | 21,30 | 2 130 USD | |
2020-06-02 | 2020-06-02 |
Collegium Pharmaceutical Inc
(COLL)
|
VP Vente planifiée |
5 761
-2.9%
20,47117 928 USD |
5 761 -2.9% | 20,47 | 117 928 USD | |
2020-06-02 | 2020-06-01 |
Collegium Pharmaceutical Inc
(COLL)
|
VP Vente planifiée |
100
-0.1%
22,082 208 USD |
100 -0.1% | 22,08 | 2 208 USD | |
2020-06-02 | 2020-06-01 |
Collegium Pharmaceutical Inc
(COLL)
|
VP Vente planifiée |
70 576
-26.2%
21,531 519 501 USD |
70 576 -26.2% | 21,53 | 1 519 501 USD | |
2019-06-04 | 2019-06-03 |
Collegium Pharmaceutical Inc
(COLL)
|
VP Vente planifiée |
7 436
-4.0%
11,5986 183 USD |
7 436 -4.0% | 11,59 | 86 183 USD | |
2019-06-04 | 2019-05-31 |
Collegium Pharmaceutical Inc
(COLL)
|
VP Vente planifiée |
5 851
-3.0%
11,5267 404 USD |
5 851 -3.0% | 11,52 | 67 404 USD |